Brief: Castle Biosciences Q2 Basic EPS USD -0.7
02/08/2023 21:05
Aug 02 (Reuters) - Castle Biosciences Q2 revenue USD 50.138 million vs. IBES estimate USD 44.2 million. * Q2 operating income USD -21.157 million * Q2 pretax profit USD -18.761 million * Q2 net income USD -18.777 million * Q2 operating expenses USD 71.295 million * Q2 adjusted gross margin 78% * Q2 gross margin 73%
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million